ConductScience.org, home

Paper487647

Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly study of melanoma patients II. Changes in serum immunoglobulins and lymphoid cell subpopulations.

Thatcher N and 2 others. Clin Exp Immunol, 1979. Cited by 5 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly study of melanoma patients II. Changes in serum immunoglobulins and lymphoid cell subpopulations. Papers, record 487647. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/487647

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly study of melanoma patients II. Changes in serum immunoglobulins and lymphoid cell subpopulations.
PubMed
Journal
Clin Exp Immunol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.2
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thatcher NN
2Swindell RR
3Crowther DD

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BCG VaccineMajor topic
Bacterial VaccinesMajor topic
MelanomaMajor topic
Propionibacterium acnesMajor topic
Humans
Immunization
Immunoglobulins
Leukocyte Count
Lymphocyte Activation
Lymphocytes
Rosette Formation
Time Factors

Source PubMed

Download CSV of topics

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
161040The effect of Corynebacterium parvum therapy on immunoglobulin class and IgG subclass levels in cancer patients.Br J Cancer1975https://conductscience.org/library/papers/61040PubMed
2186417Immunological monitoring and immunotherapy in carcinoma of the lung.Int J Cancer1976https://conductscience.org/library/papers/186417PubMed
3137880Sequential examination of lymphocyte proliferative capacity in patients with malignant melanoma receiving BCG immunotherapy.Int J Cancer1977https://conductscience.org/library/papers/137880PubMed
4343523Antitumor activity of Corynebacterium parvum.Adv Cancer Res1978https://conductscience.org/library/papers/343523PubMed
5314367
Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly sequential study of melanoma patients. I. Changes in non-specific (NK, K and T cell) lymphocytotoxicity, peripheral blood counts and delayed hypersensitivity reactions.
Clin Exp Immunol1979https://conductscience.org/library/papers/314367PubMed
6428146
Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations.
Clin Exp Immunol1979https://conductscience.org/library/papers/428146PubMed
7625264Lymphocyte function related to survival curves in patients with metastatic melanoma treated by chemoimmunotherapy.Med Pediatr Oncol1978https://conductscience.org/library/papers/625264PubMed
8597473Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma.Br J Cancer1977https://conductscience.org/library/papers/597473PubMed
91233077Cellular immunocompetence in melanoma: effect of extent of disease and immunotherapy.Br J Cancer1975https://conductscience.org/library/papers/1233077PubMed
104276248Correlation of in vivo and in vitro assays of immunocompetence in cancer patients.Cancer Res1974https://conductscience.org/library/papers/4276248PubMed
111102163Observations in immunotherapy of lymphoma and melanoma patients.Clin Exp Immunol1975https://conductscience.org/library/papers/1102163PubMed
1254235E and EAC rosetting lymphocytes in patients with carcinoma of bronchus. II. A sequential study of thirty patients: effect of BCG.Clin Exp Immunol1975https://conductscience.org/library/papers/54235PubMed
13173486E and EAC rosetting lymphocytes in patients with carcinoma of bronchus I. Some parameters of the test and of its prognostic significance.Clin Exp Immunol1975https://conductscience.org/library/papers/173486PubMed
144722915BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary report.Cancer1973https://conductscience.org/library/papers/4722915PubMed
154688801Correlation of preoperative lymphocyte reactivity with the clinical course of cancer patients.Surg Gynecol Obstet1973https://conductscience.org/library/papers/4688801PubMed
161080521Daily intravenous infusions of Corynebacterium parvum in twenty patients with disseminated cancer: a preliminary report of clinical and biologic findings.J Natl Cancer Inst1975https://conductscience.org/library/papers/1080521PubMed
17769946Monitoring of immunologic status of patients receiving BCG therapy for malignant disease.Cancer1976https://conductscience.org/library/papers/769946PubMed
18769937Nonspecific immunotherapy by Corynebacterium parvum: phase I toxicity study in 12 patients with advanced cancer.Cancer1976https://conductscience.org/library/papers/769937PubMed

Download CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/487647

GET https://conductscience.org/api/papers/v1/487647/authors